• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

common adhd medications (click for source) Medication During Pregnancy and Breastfeeding

Women with ADHD face a difficult decision on whether to keep or stop taking ADHD medication during pregnancy and breast-feeding. There aren't many studies on how to get adhd medication without diagnosis long-term exposure may affect the fetus.

A study recently published in Molecular Psychiatry shows that children exposed to adhd medication for women medication during utero do not develop neurological disorders such as hearing loss or impaired vision, febrile seizures, or IQ impairment. The authors acknowledge that more high-quality research is needed.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication must evaluate the benefits of using it against the potential dangers for the foetus. Physicians don't have the data to make unambiguous recommendations but they can provide information on risks and benefits to help pregnant women make informed choices.

A study published in Molecular Psychiatry found that women who took ADHD medications in early pregnancy did not face a significantly increased risk of fetal cardiac malformations or major birth defects that are structural. Researchers conducted a large population-based case-control study to determine the prevalence of major structural birth defects in infants born to mothers who had taken stimulants during early pregnancy and those who had not. Pediatric cardiologists and clinical geneticists examined the cases to ensure correct case classification and to minimize the possibility of bias.

The study conducted by the researchers had some limitations. The researchers were unable in the beginning to distinguish the effects of the medication from the disorder. This limitation makes it difficult for researchers to establish whether the small differences observed between the groups exposed were due to the use of medication or affected by comorbidities. Additionally, the researchers did not examine the long-term outcomes of offspring.

The study did find that babies whose mothers had taken ADHD medications during pregnancy were at slightly more risk of being admitted to the neonatal intensive care unit (NICU) than infants whose mothers had not taken any medication or had cut back on their medications prior to or during pregnancy. This increase was caused by central nervous system disorders. The higher risk of admission was not affected by the stimulant medications used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher likelihood of having to have an emergency caesarean section or having the baby was not scoring well on the Apgar scale (less than 7). These increases appear to be unrelated to the type of medication used during pregnancy.

Researchers suggest that the minor risk of using ADHD medication during pregnancies in the early stages could be offset by the greater benefits to both baby and mother of continued treatment for the woman’s disorder. Doctors should discuss with their patients about this issue and try to help them develop coping skills that can lessen the impact of her disorder in her daily functioning and her relationships.

Medication Interactions

As more women than ever are diagnosed with ADHD and being treated with medication, the issue of whether to keep or discontinue treatment during pregnancy is one that more and more physicians have to face. These decisions are usually made without clear and reliable evidence. Instead, doctors have to take into account their own experience in conjunction with the experiences of other doctors and the research on the subject.

The issue of risk to infants is particularly tricky. The research on this subject is based on observations rather than controlled studies and many of the findings are conflicting. Most studies limit their analysis to live-births, which could underestimate the severity of teratogenic effects which can cause abortions or terminations of pregnancy. The study discussed in this journal club addresses these issues by examining data on both live and deceased births.

The conclusion is that while certain studies have demonstrated that there is a positive correlation between ADHD medications and the possibility of certain birth defects, others have found no connection and the majority of studies have a neutral or slightly negative impact. As a result an accurate risk-benefit analysis is required in every case.

For a lot of women with ADHD who suffer from ADHD, the decision to stop taking medication is difficult, if not impossible. In a recent article in the Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can lead to increased depression, feelings of loneliness, and family conflict for these patients. Furthermore, a loss of medication may affect the ability to complete jobs and drive safely that are crucial aspects of a normal life for many people with ADHD.

She suggests that women who aren't sure whether to continue taking the medication or stop it due to their pregnancy should educate family members, colleagues, and their friends about the condition, the impact on daily functioning and the benefits of keeping the current treatment regimen. It can also help women feel confident about her decision. It is important to note that some medications are able to be absorbed through the placenta therefore, if a patient decides to stop taking her ADHD medication during pregnancy and breastfeeding, she must be aware that traces of the medication could be transferred to the child.

Birth Defects Risk

As the use and use of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD), increases the concern over the potential effects of these drugs on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this issue. Researchers used two massive data sets to examine more than 4.3 million pregnancy and determine if stimulant medication use increased birth defects. Researchers discovered that although the risk overall is low, the first trimester ADHD exposure to medication was associated with slightly higher risk of specific heart defects such as ventriculoseptal defect.

The researchers behind the study found no association between early use of medication and other congenital anomalies, such as facial clefting or club foot. The results are in line with previous studies that showed a small, but significant increase in cardiac malformations for women who started taking ADHD medication before the time of pregnancy. This risk increased during the latter part of pregnancy, when a lot of women began to stop taking their medication.

Women who took ADHD medication during the first trimester were more likely to need a caesarean, have a low Apgar after birth and have a baby that needed help breathing when they were born. However, the authors of the study were not able to eliminate selection bias by restricting the study to women who did not have other medical issues that could be a contributing factor to these findings.

Researchers hope that their study will help doctors when they encounter pregnant women. The researchers suggest that, while discussing risks and benefits are important, the choice regarding whether or not to stop medication should be based on the severity of each woman's ADHD symptoms and her requirements.

The authors also advise that even though stopping adhd medication adults the medication is an option, it isn't an option that is recommended due to the high prevalence of depression and other mental health problems among women who are pregnant or recently postpartum. Further, the research suggests that women who choose to stop taking their medication are more likely to have a difficult time adjusting to life without them following the birth of their baby.

Nursing

The responsibilities of being a new mother can be overwhelming. Women who suffer from ADHD are often faced with a number of difficulties when they must manage their symptoms, attend doctor appointments and prepare for the birth of a child and adjust to new routines. As such, many women decide to continue taking their ADHD medications throughout pregnancy.

The majority of stimulant drugs pass through breast milk in very small amounts, so the risk to nursing infant is very low. However, the amount of exposure to medications by the infant can differ based on the dosage, frequency it is taken and at what time the medication is administered. Additionally, different medications enter the baby’s system via the gastrointestinal tract or through breast milk. The effect on the health of a newborn is not completely known.

Some doctors may decide to stop stimulant medication during a woman's pregnancy due to the lack of research. It is a difficult decision for the woman, who must weigh the benefits of taking her medication as well as the risk to the foetus. Until more information is available, GPs should ask all pregnant patients about their experience with ADHD and whether they plan or are taking to take medication during the perinatal period.

A growing number of studies have proven that most women can safely continue taking their adhd medications for adults with anxiety medication during pregnancy and breastfeeding. In response, a growing number of patients are opting to do so. They have concluded after consulting with their physicians that the benefits of keeping their current medication outweigh possible risks.

It's important for women with ADHD who are considering breastfeeding to seek a specialist psychiatrist's guidance prior to becoming pregnant. They should review their medications with their doctor and discuss the pros and cons of continued treatment, Common Adhd Medications including non-pharmacological strategies. Psychoeducation is also required to help pregnant women with ADHD understand the symptoms and the underlying disorder. They should also learn about treatment options and strengthen the coping mechanisms. This should involve a multidisciplinary approach with the GP doctors, obstetricians and psychiatrists. Pregnancy counseling should consist of a discussion of a treatment plan for the mother as well as the child, as well as monitoring for indicators of deterioration, and, if necessary, adjustments to the medication regime.